DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PXS-5505

Generic Name: PXS-5505

Drug Type: Small Molecule

Chemical Formula: C_₁₃H_₁₃FN_₂O_₂S

CAS Number: 2409963-83-1

Unique Ingredient Identifier: DO94E28WYW

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma

Phase 1

Withdrawn

Posted: 2021/11/05

Sponsor:University of Roches...

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

Phase 1

Active, not recruiting

Posted: 2020/12/21

Sponsor:

Syntara

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy